FundedIQ
Biotechnology

AbCellera Biologics: Funding, Investors & Team (Nov 2026)

AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.

www.abcellera.com LinkedIn Vancouver, Canada 101-250 employees
Biotechnology Medical Therapeutics
Total raised
$105M
Rounds
1
Latest
Undisclosed round
May 2020

AbCellera Biologics has raised $105M across 1 funding round on record, the most recent an undisclosed round of $105M announced in May 2020.

That round is above the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

AbCellera Biologics Company Profile and Key Stats

Total funding raised
$105M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$105M in May 2020
Employees
101-250
reported band
Headquarters
Vancouver, Canada

Latest funding round on record: May 2020.

AbCellera Biologics Funding Rounds

Date
Round
Amount
Undisclosed round
$105M

AbCellera Biologics Founders and Leadership Team

Name
Role
Contact
Carl Hansen
CEO
Locked

Contact details for the AbCellera Biologics team: 1 of 1 has an email address on file.

Start 14-day free trial →

AbCellera Biologics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.9M
3,119
$2.2M

AbCellera Biologics' latest round of $105M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like AbCellera Biologics in Biotechnology and Vancouver

Companies Similar to AbCellera Biologics

Thryv Therapeutics Inc., formerly known as LQT Therapeutics Inc., is a privately owned company located in…

Series B $21.5M

Specific Biologics is creating a cutting-edge technology that includes a dual-cleaving nuclease capable of…

Series A $35.0M

Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.

Seed $420k

Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…

Undisclosed round $4.4M

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…

Undisclosed round $50.0M

Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…

Undisclosed round $260k

Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…

Undisclosed round $430k

Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…

Undisclosed round $2.5M

ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…

Undisclosed round $360k

Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…

Undisclosed round $3.1M

Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…

Undisclosed round $15.9M

ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…

Undisclosed round $1.8M

AbCellera Biologics Funding FAQs

What does AbCellera Biologics do?

AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.

How much funding has AbCellera Biologics raised?

AbCellera Biologics has raised $105M across 1 round on record. The most recent is an undisclosed round of $105M announced in May 2020.

When did AbCellera Biologics last raise funding?

AbCellera Biologics' most recent funding round on record is an undisclosed round of $105M, announced in May 2020.

Who is the CEO of AbCellera Biologics?

Carl Hansen is listed as CEO at AbCellera Biologics.

Where is AbCellera Biologics headquartered?

AbCellera Biologics is based in Vancouver, British Columbia, Canada.

How many employees does AbCellera Biologics have?

AbCellera Biologics is in the 101-250 employee band.

How does AbCellera Biologics' funding compare to other Biotechnology startups?

AbCellera Biologics' latest round of $105M is above the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's AbCellera Biologics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AbCellera Biologics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.